The numbers coming out of Rheinmetall are the stuff of investor dreams — a €64 billion order backlog, a €2.4 billion drone contract, and revenue targets approaching €14.5 billion. Yet the Düsseldorf-based defence group finds itself in a peculiar bind: the more business it books, the lower its shares sink.
On Friday, the stock touched €1,321.20, a fresh 52-week trough that leaves it more than a third below the near-€2,000 peak hit last September. Since the start of 2026, the equity has shed roughly 17.5% of its value. The disconnect between operational momentum and market sentiment has rarely been starker.
A €2.4 Billion Drone Deal That Didn’t Move the Needle
The latest piece of good news arrived on 22 April, when the Bundeswehr’s procurement office signed a framework agreement for the FV-014 loitering munition, a so-called “kamikaze drone” produced by Rheinmetall. The ceiling value of the contract stands at around €2.4 billion, with an initial call-off of approximately 2,500 units worth €300 million gross. The Bundestag’s budget committee had given its blessing on 15 April.
The FV-014, internally designated “Raider,” is an electrically powered drone in the 20-kilogram class. It carries a 4-kilogram warhead, has a range of up to 100 kilometres, and can loiter for 70 minutes. The system is designed to operate in GPS-denied environments and supports swarm operations. Rheinmetall manufactures the drone entirely within the EU, with qualification expected by September 2026 and first deliveries pencilled in for the first half of 2027.
This marks the third loitering-munition contract awarded by the German military this year. In February, the budget committee approved framework deals with Helsing and STARK, each with initial call-offs around €270 million. The FV-014 systems are slated to equip, among others, the Panzerbrigade 45 stationed in Lithuania from 2027 onwards.
The Cashflow Conundrum
While headline orders look impressive, the financial mechanics behind them are weighing on the stock. Rheinmetall currently holds critical components worth roughly €8 billion in inventory — a strategic buffer that guarantees production continuity but ties up enormous amounts of working capital. The result is a drag on cash flow that has made investors cautious.
Chief executive Armin Papperger used his appearance at the Hannover Messe to showcase the group’s production ramp-up. Artillery munition output, he noted, has increased more than tenfold since the start of the Ukraine war, and unit costs are falling as volumes rise. Yet the market appears to be looking past the operational cheerleading and focusing on the balance sheet strain.
Should investors sell immediately? Or is it worth buying Rheinmetall?
Technicals Deteriorate
Chart watchers have little to cheer about. The stock is now trading roughly 20% below its 200-day moving average, a bearish signal that often prompts further selling. The slide has been relentless: from the September 2025 high, the shares have surrendered more than a third of their value, and the year-to-date decline stands at 17.5%.
The 52-week low of €1,321.20 undershoots even the most cautious analyst estimates. Jefferies, which recently lifted its price target to €2,220 with a “Buy” rating, argues that land-defence stocks look particularly attractive after the recent pullback. Bernstein Research maintains an “Outperform” call with a €2,050 target, while Berenberg sees value at €2,100. The consensus among sell-side analysts remains firmly bullish — but the market is voting with its feet.
Joint Venture for Cruise Missiles
Alongside the drone deal, Rheinmetall is pushing into new weapons categories. The company plans to form a joint venture with Destinus to produce cruise missiles and ballistic rocket artillery. The new entity will be based in Unterlüß, Lower Saxony, with Rheinmetall taking a 51% stake. Production is expected to begin in the second half of 2026, pending regulatory approval.
The move underscores the group’s ambition to capture a broader slice of Europe’s rearmament spending, but it also adds another layer of capital commitment at a time when investors are already fretting about cash conversion.
The Q1 Reckoning
All eyes now turn to 7 May, when Rheinmetall releases its first-quarter results for 2026. Five days later, the annual general meeting will take place. The company has guided for revenue growth of 40% to 45% this year, targeting €14.0 billion to €14.5 billion. Over 90% of that sum is already covered by existing orders, providing unusually high visibility.
The question is whether management can convince the market that the record backlog is translating into near-term earnings and, crucially, cash. The margin outlook disappointed in the previous update, and investors want hard numbers — not just order-book bragging rights. Until then, the gap between Rheinmetall’s operational reality and its stock price seems set to persist.
Ad
Rheinmetall Stock: Buy or Sell?! New Rheinmetall Analysis from April 25 delivers the answer:
The latest Rheinmetall figures speak for themselves: Urgent action needed for Rheinmetall investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from April 25.
Rheinmetall: Buy or sell? Read more here...












